Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Elite", market "China A-shares", market cap "Mid $2–10B": 30 match(clear filters).

# Ticker Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 Shenzhen New Industries Biomedical 300832 · Shenzhen $5.3B
93/100 Elite
23.5%low 17.4% 10 yr+ Net cash 75% FY2025
2 Proya Cosmetics Co Ltd Class A 603605 · Shanghai $3.3B
93/100 Elite
22.1%low 13.8% 10 yr+ Net cash 66% FY2025
3 Zhejiang Weixing New Building Materials Co Ltd 002372 · Shenzhen $2.0B
92/100 Elite
23.9%low 15.2% 10 yr+ Net cash 43% FY2025
4 Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Shanghai $5.0B
91/100 Elite
19.7%low 15.7% 10 yr+ Net cash 74% FY2025
5 Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Shanghai $3.4B
91/100 Elite
21.6%low 12.2% 10 yr+ Net cash 83% FY2025
6 Hangzhou Robam Appliances Co Ltd 002508 · Shenzhen $2.1B
90/100 Elite
19.8%low 10.9% 10 yr+ Net cash 53% FY2025
7 Yealink Network Technology Corp Ltd 300628 · Shenzhen $6.9B
89/100 Elite
28.7%low 20.6% 10 yr+ Net cash 67% FY2025
8 Anhui Gujing Distillery Co Ltd 000596 · Shenzhen $7.0B
88/100 Elite
18.6%low 13.9% 10 yr+ Net cash 77% FY2025
9 Anhui Yingjia Distillery Co Ltd 603198 · Shanghai $4.4B
87/100 Elite
21.0%low 16.2% 10 yr+ Net cash 66% FY2025
10 HLA GROUP CORP LTD 600398 · Shanghai $4.2B
87/100 Elite
19.8%low 11.8% 10 yr+ Net cash 39% FY2025
11 Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · Shanghai $6.8B
86/100 Elite
21.0%low 12.8% 10 yr+ Net cash 48% FY2025
12 Zhejiang Supor Co Ltd 002032 · Shenzhen $4.8B
86/100 Elite
28.8%low 23.7% 10 yr+ Net cash 26% FY2025
13 Xiamen Faratronic Co Ltd 600563 · Shanghai $4.3B
86/100 Elite
20.2%low 17.3% 10 yr+ Net cash 39% FY2025
14 Livzon Pharmaceutical Group Inc 000513 · Shenzhen $3.9B
86/100 Elite
16.0%low 10.2% 10 yr+ Net cash 63% FY2025
15 Shanghai M&G Stationery Inc 603899 · Shanghai $3.0B
86/100 Elite
20.8%low 14.1% 10 yr+ Net cash 23% FY2025
16 G-bits Network Technology Xiamen Co Ltd 603444 · Shanghai $3.9B
84/100 Elite
28.1%low 19.3% 10 yr+ Net cash 90% FY2025
17 Jiangzhong Pharmaceutical Co Ltd 600750 · Shanghai $2.3B
84/100 Elite
15.8%low 12.2% 10 yr+ Net cash 66% FY2025
18 Jafron Biomedical Co Ltd 300529 · Shenzhen $2.1B
84/100 Elite
23.3%low 13.9% 10 yr+ Net cash 83% FY2025
19 Huadong Medicine Co Ltd 000963 · Shenzhen $7.1B
83/100 Elite
17.6%low 13.5% 10 yr+ Net cash 30% FY2025
20 Lao Feng Xiang Co Ltd A 600612 · Shanghai $2.6B
83/100 Elite
18.4%low 11.6% 10 yr+ Net cash 8% FY2025
21 Shandong Himile Mechanical Science & Technology Co Ltd 002595 · Shenzhen $8.5B
82/100 Elite
18.1%low 16.2% 10 yr+ Net cash 33% FY2025
22 Chongqing Brewery Co Ltd 600132 · Shanghai $3.1B
82/100 Elite
49.8%low 14.7% 10 yr+ Net cash 46% FY2025
23 Dashenlin Pharm Grp Co Ltd 603233 · Shanghai $3.0B
82/100 Elite
18.2%low 13.3% 10 yr+ 0.0× 38% FY2025
24 Shanghai Friendess Electronics Tech 688188 · Shanghai $5.9B
81/100 Elite
27.3%low 11.2% 10 yr+ Net cash 82% FY2025
25 Huali Industrial Group Company Limited 300979 · Shenzhen $5.8B
81/100 Elite
30.9%low 19.7% 9 yr Net cash 23% FY2025
26 Hisense Kelon Electrical Holdings Co Ltd 000921 · Shenzhen $5.3B
81/100 Elite
19.1%low 9.4% 10 yr+ Net cash 21% FY2025
27 Shanghai Huace Navigation Technology Ltd 300627 · Shenzhen $3.2B
81/100 Elite
17.0%low 12.2% 10 yr+ Net cash 60% FY2025
28 AIMA Technology Group Co Ltd 603529 · Shanghai $2.7B
81/100 Elite
25.4%low 13.3% 10 yr+ Net cash 15% FY2025
29 China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · Shenzhen $6.0B
80/100 Elite
14.4%low 11.6% 10 yr+ Net cash 60% FY2025
30 Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · Shenzhen $3.1B
80/100 Elite
16.2%low 13.1% 10 yr+ Net cash 66% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.